One of this week's 2 Bay Area biotech IPOs just got bigger
July 16, 2020 at 10:11 AM EDT
If it hits the top of its targets, the company could have a market cap of about $1.2 billion, more than doubling its previous valuation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|